VINORELBINE PIERRE FABRE vinorelbine 80mg (as tartrate) capsule blister pack
देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: Department of Health (Therapeutic Goods Administration)
सार्वजनिक आकलन रिपोर्ट
(PAR)
12-05-2019
अनुरोध भेजा।
सक्रिय संघटक:
vinorelbine tartrate, Quantity: 110.8 mg (Equivalent: vinorelbine, Qty 80 mg)
थमां उपलब्ध:
Pierre Fabre Australia Pty Ltd
फार्मास्यूटिकल फॉर्म:
Capsule, soft
रचना:
Excipient Ingredients: ethanol; purified water; glycerol; macrogol 400; Gelatin; iron oxide yellow; titanium dioxide; medium chain triglycerides; ascorbyl palmitate; phosphatidyl choline; dl-alpha-tocopherol; sorbitol; 1,4-sorbitan; mannitol; hydrogenated starch hydrosylate; hypromellose; propylene glycol; isopropyl alcohol; aluminium chloride; sodium hydroxide; cochineal
प्रशासन का मार्ग:
Oral
पैकेज में यूनिट:
1 tablet
प्रिस्क्रिप्शन प्रकार:
(S4) Prescription Only Medicine
चिकित्सीय संकेत:
Non-small cell lung cancer: VINORELBINE PIERRE FABRE is indicated for the first line treatment of advanced non-small cell lung cancer, as a single agent or in combination.,Breast cancer: VINORELBINE PIERRE FABRE is indicated for the treatment of advanced breast cancer after failure of standard therapy as a single agent or in combination.
उत्पाद समीक्षा:
Visual Identification: pale yellow, soft capsule printed N80.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 30 Months; Container Temperature: Store at 2 to 8 degrees Celsius
प्राधिकरण का दर्जा:
Registered
प्राधिकरण की तारीख:
2005-05-31
